4//SEC Filing
PIERIS PHARMACEUTICALS, INC. 4
Accession 0000899243-17-012544
$PVLACIK 0001583648operating
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:30 PM ET
Size
6.9 KB
Accession
0000899243-17-012544
Insider Transaction Report
Form 4
KIRITSY CHRISTOPHER P
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-04-21−5,000→ 25,000 totalExercise: $1.59Exp: 2026-09-20→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2017-04-21$1.59/sh+5,000$7,950→ 5,000 total
Footnotes (1)
- [F1]The stock option vests in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001583648
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 6:30 PM ET
- Size
- 6.9 KB